Showing results (291-300 of 332) with videos related to

Sort By:
Pageof 34
Applied Clinical Informatics|December 22, 2021
A Mobile, Electronic Health Record-Connected Application for Managing Team Workflows in Inpatient CareJacqueline M Soegaard Ballester, Geoffrey D Bass, Richard Urbani, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Lestaurtinib's antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancerEsther P B Rodman, Michael J Emch, Xiaonan Hou, et al.
NPJ Precision Oncology|July 11, 2025
Lestaurtinib's antineoplastic activity converges on JAK/STAT signaling to inhibit treatment naïve and therapy resistant forms ovarian cancerEsther P B Rodman, Michael J Emch, Xiaonan Hou, et al.
The Review of Scientific Instruments|June 1, 2015
A slow neutron polarimeter for the measurement of parity-odd neutron rotary powerW M Snow, E Anderson, L Barrón-Palos, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 22, 2023
Effect of High-Intensity Statin Therapy on Atherosclerosis (IBIS-4): Manual Versus Automated Methods of IVUS AnalysisRonald D Bass, Héctor M García-García, Yasushi Ueki, et al.
Critical Care Explorations|April 4, 2022
Six-Month Impairment in Cognition, Mental Health, and Physical Function Following COVID-19-Associated Respiratory FailureJason H Maley, Danielle K Sandsmark, Alison Trainor, et al.
Journal of Neurology|June 26, 2020
Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223Brian Steingo, Yaser Al Malik, Ann D Bass, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2021
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing dataAlasdair J Coles, Joanne L Jones, Patrick Vermersch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2019
Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and managementAdam Cuker, Ann D Bass, Congor Nadj, et al.
Neurology. Clinical Practice|August 26, 2024
The Recovery of Consciousness via Evidence-Based Medicine and Research (RECOVER) Program: A Paradigm for Advancing NeuroprognosticationDavid Fischer, Benjamin S Abella, Geoffrey D Bass, et al.
Pageof 34